All tenders
75N91020F00039

COVID-19 ACTIV3 Clinical Trial Research

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number
75N91020F00039
Government level
Federal
Solicitation type
Healthcare & Medical
Title
COVID-19 ACTIV3 Clinical Trial Research
Source ID
usa-75N91020F00039

Details

Location
United States

Summary

National Institutes of Health research contract for the ACTIV3 COVID-19 clinical trial program, focusing on therapeutic research and medical investigation related to the pandemic response.

Description

NIAID COVID-19 ACTIV3 Awarded to: LEIDOS BIOMEDICAL RESEARCH INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER

Dates

Publication
2020/09/02 12:00:00 AM UTC
Closing date
2027/02/28 12:00:00 AM UTC

Estimated value

$159.1M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-09-12, 10:18:51 p.m.

Data refreshed every 2 hours